Medicine
Ketorolac 60 mg/2 mL injection
Ketorolac 60 mg/2 mL injection is a generic prescription medicine for intramuscular use, made by 19 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20 to 25°C (68 to 77°F). Protect from light.
Key facts
- Active ingredient (INN)
- Ketorolac
- Brand
- Sold under the generic name
- Strength
- 60 mg/2 mL
- Dosage form
- Injection
- Route
- Intramuscular
- Packs
- 25 vials of 2 mL, 1 vial of 2 mL, 10 vials of 2 mL and 25 more
- Manufacturers
- EugiaIndiaAnthea PharmaIndiaCaplin SterilesIndiaGland PharmaIndiaGlenmark PharmaceuticalsIndiaFresenius KabiAsclemedHealthFirstHospiraOnesource Specialty Pharma
- Origin register
- US FDA, United States
- Storage
- Store at 20 to 25°C (68 to 77°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- M01AB15 Ketorolac
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 October 2000
- Identifiers
- RxCUI 1665459, 860092, 1665461 +3DailyMed set ID 004588ba-e109-4a53-9c9d-a42dea9bb848, d1920335-8e45-4960-b6e9-e6f1f9e6820c, 588b4804-4ac5-4b96-947e-354029ea4df9 +23NDC 76420-184, 63323-162, 65145-147 +21Application ANDA074802, ANDA075784, ANDA217789 +9
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 25 vial in 1 carton / 2 mL in 1 vial | 83854-024-25 | Anthea PharmaIndia | 25 September 2026 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 65145-147-25 | Caplin SterilesIndia | 4 October 2024 |
| 1 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 55150-341-01 | EugiaIndia | 20 October 2020 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 55150-341-25 | EugiaIndia | 20 October 2020 |
| 10 vial in 1 carton / 2 mL in 1 vial | 68083-134-10 | Gland PharmaIndia | 1 December 2016 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 68462-757-25 | Glenmark PharmaceuticalsIndia | 1 February 2024 |
| 25 vial, single-use in 1 tray / 2 mL in 1 vial, single-use | 63323-162-02 | Fresenius Kabi | 18 October 2000 |
| 25 vial, single-dose in 1 tray / 2 mL in 1 vial, single-dose | 63323-162-14 | Fresenius Kabi | 18 October 2000 |
| 25 vial, single-use in 1 tray / 2 mL in 1 vial, single-use | 63323-162-26 | Fresenius Kabi | 18 October 2000 |
| 24 blister pack in 1 carton / 1 syringe, glass in 1 blister pack / 2 mL in 1 syringe, glass | 76045-105-20 | Fresenius Kabi | 2 November 2015 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 83270-155-03 | Onesource Specialty Pharma | 30 September 2023 |
| 1 syringe, glass in 1 carton / 2 mL in 1 syringe, glass | 83270-159-01 | Onesource Specialty Pharma | 30 September 2023 |
| 10 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 43066-053-10 | Baxter Healthcare | 19 May 2026 |
| 25 vial in 1 carton / 2 mL in 1 vial | 72266-119-25 | Fosun Pharma | 23 June 2023 |
| 25 vial in 1 carton / 2 mL in 1 vial | 0641-6043-25 | Hikma Pharmaceuticals | 21 July 2004 |
| 25 vial, single-dose in 1 tray / 2 mL in 1 vial, single-dose | 0409-3796-01 | Hospira | 30 October 2015 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 0409-3796-25 | Hospira | 27 January 2025 |
| 30 vial in 1 carton / 2 mL in 1 vial | 0487-6232-01 | Nephron Pharmaceuticals | 8 September 2020 |
| 2 mL in 1 vial, single-dose | 76420-184-02 | Asclemed | 18 November 2020 |
| 2 mL in 1 vial | 76420-272-02 | Asclemed | 2 September 2022 |
| 25 pouch in 1 box / 1 vial, single-dose in 1 pouch / 2 mL in 1 vial, single-dose | 51662-1669-3 | HealthFirst | 30 October 2015 |
| 25 pouch in 1 case / 1 vial in 1 pouch / 2 mL in 1 vial | 51662-1702-3 | HealthFirst | 18 October 2000 |
| 25 vial in 1 carton / 2 mL in 1 vial | 70518-3800-0 | Remedyrepack | 19 July 2023 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 70518-4253-0 | Remedyrepack | 11 January 2025 |
| 1 vial in 1 bag / 2 mL in 1 vial | 0404-9997-02 | Henry Schein | 25 August 2023 |
| 1 vial in 1 bag / 2 mL in 1 vial | 71872-7288-1 | Medical Purchasing Solutions | 12 April 2022 |
| 2 mL in 1 vial | 84549-119-25 | ProPharma Distribution | 10 October 2025 |
| 25 vial in 1 carton / 2 mL in 1 vial | 85766-017-25 | Sportpharm | 4 September 2026 |
| 25 vial in 1 carton / 2 mL in 1 vial | 62332-601-25 | — | 2 November 2022 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 31722-307-25 | — | 20 June 2023 |
| 25 vial in 1 carton / 2 mL in 1 vial | 25021-701-02 | — | 5 September 2014 |
| 25 vial in 1 carton / 2 mL in 1 vial | 70512-844-25 | — | 22 October 2024 |
| 25 vial in 1 carton / 2 mL in 1 vial | 50090-6772-0 | — | 24 October 2023 |
| 1 vial in 1 carton / 2 mL in 1 vial | 50090-6772-1 | — | 24 October 2023 |
| 1 vial in 1 bag / 2 mL in 1 vial | 71872-7328-1 | — | 6 September 2024 |
| 25 vial in 1 carton / 2 mL in 1 vial | 85766-299-25 | — | 22 October 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 30 November 1989 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Ketorolac 60 mg/2 mL injection.
Other strengths and forms of Ketorolac
Clinical summary
Ketorolac is a cyclooxygenase inhibitor indicated for the temporary relief of ocular itching due to seasonal allergic conjunctivitis, among other approved uses. It is available as injection, tablets and eye drops for intramuscular, intravenous and oral use. MedsAcross supplies Ketorolac for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about KetorolacFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Acular prescribing information (Allergan) · U.S. National Library of Medicine, DailyMed
Need Ketorolac 60 mg/2 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.